Sequenom Inc. SQNM Launches Screening Test

September 17, 2009 - Shares of Sequenom Inc. (SQNM) are popping in pre market trading due to the news below. SQNM stock is $6.27 Up 9.23%.


SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test

SEQUENOM, Inc. (Nasdaq: SQNM) today announced that the company's first laboratory developed test, the SensiGene(TM) Cystic Fibrosis (CF) Carrier Screening test, has been launched. This test is available exclusively through the Sequenom Center for Molecular Medicine, a next-generation CLIA (Clinical Laboratory Improvement Amendments, 1988) molecular diagnostic laboratory and a wholly-owned subsidiary of Sequenom, Inc.

"As the world's population becomes more of a melting pot in terms of ethnicity and diversity, a more comprehensive test like the SensiGene Cystic Fibrosis Carrier Screening test is essential in the world of genetic testing," said Lee P. Shulman MD, Professor in Obstetrics and Gynecology and Chief of the Division of Reproductive Medicine at the Feinberg School of Medicine at Northwestern University. Full Article

I will be watching two key resistance levels located at $6.53 & $7.08. A close above $7.08 would be very bullish!.

For More Stock Market Updates, visit , http://daytradingstockblog.blogspot.com/ or Subscribe for FREE